Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axid in Infants with GERD
NCT00373334Phase 3Completed
- Sponsor
- Braintree Laboratories
- Start
- Aug 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nizatidine in gastroesophageal reflux disease (GERD), sponsored by Braintree Laboratories. Started Aug 2006; status: completed.
02
Drugs
nizatidine
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00373334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373334.